Egret Pharma (Shanghai) Limited is a pharmaceutical research and development company directing its efforts to discover new medications for major diseases worldwide. Located in the Zhangjiang Hi-Tech Park of Pudong New Area in Shanghai, Egret is a majority Chinese-owned company established by a team of entrepreneurs and scientists with global experience in top academic centers and multinational pharmaceutical corporations. Our strategy is to be at the forefront of new technology development of novel technologies and practices for entrepreneurial innovation in China and to bring the best management principles of global drug development to bear on the challenges of the marketplace. Egret Pharma has created a state-of-the-art working environment and research management system. Our company is equipped with modern instruments and facilities required for a cutting edge pharmaceutical discovery group. We have successfully built the infrastructure required to support integrated pharmaceutical research platforms in an electronic R&D environment.
View Top Employees from 白鹭医药技术(上海)有限公司Website | http://www.egretpharma.com |
Revenue | $1 million |
Employees | 7 (2 on RocketReach) |
Industry | Medical Equipment Manufacturing, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
SIC | SIC Code 738 Companies, SIC Code 73 Companies |
NAICS | NAICS Code 561 Companies, NAICS Code 56 Companies |
Looking for a particular 白鹭医药技术(上海)有限公司 employee's phone or email?
The 白鹭医药技术(上海)有限公司 annual revenue was $1 million in 2024.
2 people are employed at 白鹭医药技术(上海)有限公司.
白鹭医药技术(上海)有限公司 is based in Shanghai, Shanghai.
The NAICS codes for 白鹭医药技术(上海)有限公司 are [561, 56].
The SIC codes for 白鹭医药技术(上海)有限公司 are [738, 73].